⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMY News
Bristol-Myers Squibb Co.
Beeline Medicines Announces Upsized Series A of $426.3 Million to Advance Category-Leading Autoimmune and Inflammatory Disease Portfolio
globenewswire.com
BMY
The Quest to Repair What Multiple Sclerosis Takes Away
globenewswire.com
QNTM
NVS
MRK
TGTX
BMY
NVIDIA Announces BioNeMo Agent Toolkit — Tools for Agents to Accelerate Scientific Discovery
globenewswire.com
NVDA
LRCX
AMAT
SNOW
CDNS
MRVL
MU
SMCI
AMD
INTC
QCOM
GOOG
MSFT
AMZN
LLY
NTRS
REGN
GILD
BMY
PFE
MRNA
BIIB
VRTX
CRSP
EXAS
ROST
DSY
TMO
Ichnos Glenmark Innovation (IGI) Announces Appointment of Mariana Cota Stirner, M.D., Ph.D., as Chief Medical Officer
globenewswire.com
ABBV
BMY
NVS
Questex’s PODD, the Premier Gathering for Drug Delivery Industry Leaders, Announces the 16th Annual Conference Agenda
globenewswire.com
ABBV
ALNY
ASTL
AZN
BIIB
BMY
CSL
LLY
GILD
GSK
MRK
NVS
NVO
PFE
REGN
SNY
SUN
TEVA
UPST
VRTX
Entact Bio Appoints John G. Houston, Ph.D., to its Board of Directors
globenewswire.com
ARVN
BMY
SystImmune Announces First Approval of Iza-bren for the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma in China
prnewswire.com
BMY
Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing Healthcare Investments | DelveInsight
globenewswire.com
BIIB
AMGN
BMY
IMVT
AZN
MRK
CTNT
REGN
GILD
Biond Biologics Appoints Giovanni Selvaggi, M.D., as Chief Medical Officer ("CMO")
prnewswire.com
BMY
NVS
GSK
Bristol Myers Squibb Announces Dividend
businesswire.com
BMY